Physician

Thomas Renz, D.O.

According to 2025 Medicare claims, Thomas Renz, D.O. (NPI: 1548256597) practices orthopedic surgery in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is LANCASTER ORTHOPEDIC GROUP, INC. (NPI: 1598740508; TIN: 232936169) and primary practice location at 17601-1812. Renz is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Renz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 781 traditional Medicare patients, billed 6,795 HCPCS/CPT codes, and received $372,111 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 291 prescription claims across 163 beneficiaries totaling $4,963 in drug costs, led by Eliquis (Apixaban). DME data shows 64 claims. Open Payments data shows 7 records totaling $12,159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,712 and ending at $4,963. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $9,355 to $7,814.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	667	5,058	$284,247
2016	765	4,616	$303,621
2017	747	5,061	$305,846
2018	787	4,658	$318,824
2019	773	4,865	$355,358
2020	711	4,113	$332,980
2021	736	3,904	$386,262
2022	684	6,291	$358,933
2023	691	6,079	$340,235
2024	781	6,795	$372,111

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	229	350	$5,712
2016	228	335	$3,893
2017	244	350	$5,570
2018	242	347	$4,662
2019	202	272	$6,119
2020	164	267	$3,204
2021	158	260	$3,077
2022	194	319	$4,375
2023	183	319	$5,328
2024	163	291	$4,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	14	$1,499
2016	40	40	$3,365
2017	84	87	$7,903
2018	39	39	$3,154
2019	67	68	$7,691
2020	61	62	$6,989
2021	38	38	$4,240
2022	26	26	$2,948
2023	27	41	$5,482
2024	17	64	$6,065

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	387	533	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	250	350	$61
20610	Aspiration and/or injection of fluid from large joint	276	421	$45
73564	X-ray of knee, 4 or more views	254	317	$30
73562	X-ray of knee, 3 views	229	295	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	11	180	$3,509
Methylprednisolone	Methylprednisolone	62	397	$335
Celecoxib	Celecoxib	17	510	$280
Cefadroxil	Cefadroxil	18	704	$251
Gabapentin	Gabapentin	40	1,427	$197

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	36	$2,534
L1820	Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	N	17	17	$2,224
E1811	Static progressive stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories	Y	N/R	11	$1,306

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$37	Ethicon US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$12,122	Lancaster General Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Renz, D.O.?

Tedicare shows public-source Medicare data for Thomas Renz, D.O. (NPI 1548256597), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Renz, D.O. have ACO affiliation data?

Thomas Renz, D.O. is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Thomas Renz, D.O.?

Thomas Renz, D.O. is linked to LANCASTER ORTHOPEDIC GROUP, INC. (billing NPI 1598740508) in the available physician profile data.

Does Thomas Renz, D.O. have Open Payments data?

Thomas Renz, D.O. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.